SBP solbec pharmaceuticals limited

genentech up $11 billion, page-15

  1. skint
    5,882 Posts.
    lightbulb Created with Sketch. 150
    clock Created with Sketch.
    22/03/05
    19:08
    Post #: 841895
    re: skint/refresher 4-6 weeks to USA listing is good . At least in the USA there are drugs to compare with Coramsine . To get a partial response in 16% of patients against mixed refractory tumours is unusual . To find the ones that compare in their first phase 1 against solid mixed tumours is easy . Just research all the blockbusters .
    Cheers
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
IGO IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
right-arrow Created with Sketch.
MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
right-arrow Created with Sketch.
FHE Frontier Energy lines up $215 million debt financing from Mike Cannon-Brookes-backed Infradebt
right-arrow Created with Sketch.
TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.